The North American experience with photopheresis.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 10079806)

Published in Ther Apher on February 01, 1999

Authors

J A Zic1, J L Miller, G P Stricklin, L E King

Author Affiliations

1: Division of Dermatology, Vanderbilt University School of Medicine/Nashville Veterans Affairs Medical Center, Tennessee, USA.

Articles by these authors

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98

Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39

Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30

The effect on blood-pressure of organ extracts. J Physiol (1911) 2.24

Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest (2000) 2.21

Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun (1975) 2.12

Fluorescent treponemal antibodies in fractionated syphilitic sera. The immunoglobulin class. Arch Dermatol (1969) 2.06

Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem (1983) 1.89

pepM is an essential gene in Salmonella typhimurium. J Bacteriol (1989) 1.85

Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol (1994) 1.78

The visualization of human erythrocyte membrane proteins and glycoproteins in SDS polyacrylamide gels employing a single staining procedure. Anal Biochem (1976) 1.72

Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71

N-terminal methionine-specific peptidase in Salmonella typhimurium. Proc Natl Acad Sci U S A (1987) 1.66

Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med (1987) 1.66

Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci U S A (1986) 1.63

Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60

Effect of speaking rate on the perceptual structure of a phonetic category. Percept Psychophys (1989) 1.59

Modulation of fibroblast functions by interleukin 1: increased steady-state accumulation of type I procollagen messenger RNAs and stimulation of other functions but not chemotaxis by human recombinant interleukin 1 alpha and beta. J Cell Biol (1988) 1.58

Processing of the N termini of nascent polypeptide chains requires deformylation prior to methionine removal. J Mol Biol (1999) 1.57

Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol (1986) 1.56

Articulation rate and its variability in spontaneous speech: a reanalysis and some implications. Phonetica (1984) 1.52

The nucleotide sequence of the B gene of bacteriophage Mu. Nucleic Acids Res (1984) 1.51

Serum androgens and depression in women with facial hirsutism. J Am Acad Dermatol (1992) 1.50

The TPI and FTA-ABS tests in treated late syphilis. JAMA (1968) 1.50

A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins. Transfusion (2001) 1.49

Human skin fibroblast collagenase inhibitor. Purification and biochemical characterization. J Biol Chem (1983) 1.49

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol (1992) 1.48

Mercury exposure and cutaneous disease. J Am Acad Dermatol (2000) 1.47

Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47

Some effects of later-occurring information on the perception of stop consonant and semivowel. Percept Psychophys (1979) 1.47

Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol (1998) 1.46

Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol (2000) 1.45

The dynamic link between the integrity of the immune system and zinc status. J Nutr (2000) 1.45

Amplification and purification of the bacteriophage Mu encoded B transposition protein. J Biol Chem (1985) 1.43

Epidurals redefined in analgesia and anesthesia: a distinction with a difference. J Obstet Gynecol Neonatal Nurs (1996) 1.42

Role of epidermal growth factor in carcinogenesis. Cancer Res (1986) 1.41

GnRH agonists: gonadorelin, leuprolide and nafarelin. Am Fam Physician (1991) 1.40

Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles. Genes Dev (1993) 1.40

An evaluation of the accuracy of residency applicants' curricula vitae: are the claims of publications erroneous? J Am Acad Dermatol (1996) 1.40

Marrow aplasia and sulindac. Ann Intern Med (1980) 1.40

Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry (1983) 1.39

GFPcre fusion vectors with enhanced expression. Anal Biochem (1999) 1.39

Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest (1994) 1.39

Finasteride for benign prostatic hyperplasia. Am Fam Physician (1992) 1.38

A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37

Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res (1985) 1.37

Modulation of metarhodopsin formation by cholesterol-induced ordering of bilayer lipids. Biochemistry (1990) 1.36

Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods (1994) 1.36

Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry (1997) 1.36

Phonetic prototypes: influence of place of articulation and speaking rate on the internal structure of voicing categories. J Acoust Soc Am (1992) 1.35

Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ (1993) 1.33

Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans. Vet Pathol (2010) 1.32

Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res (1999) 1.31

Characterization by electrophoresis of epidermal growth factor stimulated phosphorylation using A-431 membranes. Biochemistry (1980) 1.31

Primary structure of phage mu transposase: homology to mu repressor. Proc Natl Acad Sci U S A (1985) 1.30

Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30

What is the 'true' function of skin? Exp Dermatol (2002) 1.26

Management of alopecia areata. BMJ (2010) 1.25

Treated late syphilis: immunoglobulin class of antibodies reactive with Treponema pallidum. J Invest Dermatol (1969) 1.24

Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem (1997) 1.23

Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol (1990) 1.23

EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol (1991) 1.22

Erosive arthritis associated with apatite crystal deposition. Arthritis Rheum (1981) 1.22

Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. A case report and review of secondary squamous cell carcinomas. J Am Acad Dermatol (1981) 1.21

Quantification of apoptotic events in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol (1995) 1.21

Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood (1982) 1.20

Identification of the substance binding pemphigus antibody and concanavalin A in the skin. J Invest Dermatol (1974) 1.20

Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J Virol (1996) 1.20

Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology (1993) 1.17

Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res (1996) 1.17

Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun (2005) 1.16

Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res (2001) 1.15

Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci U S A (1985) 1.15

Gene therapy for human hemoglobinopathies. Proc Soc Exp Biol Med (1993) 1.15

What causes alopecia areata? Exp Dermatol (2013) 1.14

Interconversion of metarhodopsins I and II: a branched photointermediate decay model. Biochemistry (1990) 1.14

Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology (1998) 1.14

Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol (1984) 1.14

Necrotic arachnidism. J Am Acad Dermatol (2001) 1.13

The gelatinolytic activity of human skin fibroblast collagenase. J Biol Chem (1982) 1.12

Nineteen documented cases of Loxosceles reclusa envenomation. J Am Acad Dermatol (2001) 1.12

Isolation and mapping of Mu nu mutants which grow in him mutants of E. coli. Virology (1982) 1.12

Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol (1996) 1.12

Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem (1986) 1.10

Scavenger-receptor targeted photodynamic therapy. Photochem Photobiol (2000) 1.10

Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol (1995) 1.10

Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol (2008) 1.09

Plasmin inhibition of thrombin-induced platelet aggregation. Thromb Diath Haemorrh (1975) 1.09

Gene expression in proliferating human erythroid cells. Genomics (1999) 1.08

Psoriatic acro-osteolysis without arthritis. A case study. J Bone Joint Surg Am (1971) 1.07

Calcium effects on human erythrocyte membrane proteins. Biochim Biophys Acta (1977) 1.07

The psychogeriatric nurse in home health care: use of research to develop the role. Clin Nurse Spec (1996) 1.07

A truncated form of the bacteriophage Mu B protein promotes conservative integration, but not replicative transposition, of Mu DNA. Cell (1985) 1.07

Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins. J Cell Biochem (1986) 1.06

Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis (1987) 1.06

Quantitative determination of EGF-R during epidermal wound healing. J Invest Dermatol (1992) 1.06

Differentiation of a human leukemia cell line and expression of collagenase inhibitor. Proc Natl Acad Sci U S A (1985) 1.05

Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality. J Clin Endocrinol Metab (1995) 1.04

Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis. Arthritis Res Ther (2006) 1.04